
In the realm of cosmetic procedures across the United States, the injection of substances derived from adipose tissue sourced from deceased individuals has been in practice for roughly a decade, according to reporting by the French publication Le Point.
This material is utilized for various augmentations, such as breast enlargement, buttock contouring, filling in skin indentations, and adding volume to the cheekbones. These treatments are administered entirely within legal parameters.
The mechanism, as described in the article, involves extensive purification of the biomaterial harvested from deceased donors. Every trace of the genetic material is meticulously removed. Only once this extensive cleansing is complete is the resulting preparation administered to recipients.
Proponents of this technique assert its safety, attributing it to this rigorous processing. Furthermore, they maintain that following injection, the recipient’s own cells subsequently assimilate the foreign fat, effectively converting it into the patient’s own tissue.
This methodology has received official sanction from the U.S. Food and Drug Administration (FDA). Increasingly, individuals are opting for this technological approach, moving away from the conventional method of autologous fat grafting.